Scrip | What Does 2022 Hold For Biopharma?

Feb 2022

Originally published by SCRIP on February 8 , 2022.

James West, Director in Lincoln’s Healthcare Group shares that there has been increased private equity firm’s interest in the Biopharma space and expects continued activity in this sphere for the year 2022 .

Click here to view the full article.

Summary

Contributor

Related Perspectives

Mint | Hospital investors line up over $2 bn in exits as covid-19 recedes

Originally published by Mint on May 16, 2022. Lincoln International’s Gaurav Marathe, Managing Director and CEO India, discusses hospital chain performance during the pandemic and future considerations for investors. Click here… Read More

The Corner Series Podcast | Investor Interest: What’s Happening in Home Healthcare?

Barry Freeman, Managing Director in Lincoln’s Healthcare Group, joins Geoff Cockrell, host of the The Corner Series podcast, to discuss trends and investing opportunities in home health, hospice and palliative… Read More

M&A Activity Remains Strong for Companies Supporting Employer-Sponsored Health Benefits

Employer-sponsored, self-funded medical plans have grown in popularity since the implementation of ERISA in the 1970s and now cover nearly two-thirds of all employees and one-third of all Americans. Medical… Read More

Scale your Career: What Makes a Good Investment Banker Great?

For new analysts and associates, communication, collaboration and coordination are essential components of a successful investment banking career. Individuals who can communicate and collaborate effectively with colleagues across title levels… Read More